Combining miR-23b exposure with mesenchymal stem cell transplantation enhances therapeutic effects on EAE
- 1 January 2021
- journal article
- research article
- Published by Elsevier BV in Immunology Letters
- Vol. 229, 18-26
- https://doi.org/10.1016/j.imlet.2020.11.007
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81430035, 81771305, 81870955)
This publication has 41 references indexed in Scilit:
- Exosomes with membrane‐associated TGF‐β1 from gene‐modified dendritic cells inhibit murine EAE independently of MHC restrictionEuropean Journal of Immunology, 2013
- Gene Therapy of Multiple Sclerosis Using Interferonβ-Secreting Human Bone Marrow Mesenchymal Stem CellsBioMed Research International, 2013
- microRNA Regulation of Inflammatory ResponsesAnnual Review of Immunology, 2012
- T cells in multiple sclerosis and experimental autoimmune encephalomyelitisClinical and Experimental Immunology, 2010
- The anti-glioma effect of suicide gene therapy using BMSC expressing HSV/TK combined with overexpression of Cx43 in glioma cellsCancer Gene Therapy, 2009
- Reciprocal effect of mesenchymal stem cell on experimental autoimmune encephalomyelitis is mediated by transforming growth factor-β and interleukin-6Clinical and Experimental Immunology, 2009
- Bone marrow stromal cells attenuate sepsis via prostaglandin E2–dependent reprogramming of host macrophages to increase their interleukin-10 productionNature Medicine, 2008
- Activation of the cAMP pathway synergistically increases IL-1-induced IL-6 gene expression in FRTL-5 thyroid cells: Involvement of AP-1 transcription factorsMolecular and Cellular Endocrinology, 2008
- Experimental Autoimmune Encephalomyelitis in the MouseCurrent Protocols in Immunology, 2007
- Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cellsNature, 2006